The Economics of cardiovascular disease research stream at Deakin Health Economics’ expertise is in the economic appraisal of cardiovascular disease (CVD).
CVD is one of Australia’s national health priorities. The Economics of Cardiovascular Disease research stream focusses on the economics of stroke and coronary heart disease, ranging from prevention through to treatment, management and rehabilitation. The stream undertakes a wide range of research with the aim of informing evidenced-based, cost-effective approaches for the prevention and management of CVD nationally and internationally.
Our Economics of cardiovascular disease research stream leaders is A/Prof Lan Gao.
Email: lan.gao@deakin.edu.au
Research Team
Staff of the Economics of cardiovascular disease research stream include:
Our research
Trial-based Economic Evaluations
We collaborate with a range of clinicians and researchers to ensure that clinical trials have robust and practical economic evaluations well planned in advance of trial commencement. Our evaluations include within-trial cost-efficacy analyses of CVD prevention interventions (medications, lifestyle interventions, rehabilitation, etc.), treatments (medications and health technologies), and health services. We also conduct economic evaluations of interventions not related to clinical trials to estimate the cost-effectiveness of real-world programs.
Contact: Dr Lan Gao
Email: lan.gao@deakin.edu.au
Priority Setting Studies and Modelled Economic Evaluations
We conduct priority-setting studies where multiple policy relevant CVD prevention/treatment interventions are evaluated using consistent methodology in order to inform decision-makers on the economic credentials of various interventions in order to set priorities. We use the “Assessing Cost-Effectiveness” (ACE) methodology which explicitly incorporates not only the cost-effectiveness of the intervention but also other considerations of importance to decision-makers (strength of evidence, equity, acceptability to various stakeholders, feasibility and sustainability) into the evaluation framework.
The team is experienced in the application of modelling technique to simulate the long-term health and economic outcomes with the application of new or existing CVD prevention/treatment interventions from different perspectives to assist reimbursement decision-making.
Contact: Alfred Deakin Professor Marj Moodie
Email: marj.moodie@deakin.edu.au
Burden of Disease Studies
The economics of CVD team has conducted studies to quantify the economic/psychological burden of disease due to CVD for various populations. Burden of disease studies inform the policy formulation and priority setting.
Contact: Dr Lan Gao
Email: lan.gao@deakin.edu.au
Feature publications and reports
Brief examples of our work spanning these areas of research include: